Epidermolysis bullosa simplex: genes and variants
Explore variant evidence for Epidermolysis bullosa simplex across 2 analyzed proteins (KRT5, KRT14). Linked ClinVar records include 24 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Epidermolysis bullosa simplex
KRT5: Keratin, type II cytoskeletal 5
It pairs with keratin 14 to form the primary intermediate-filament scaffold of basal epidermal keratinocytes. Dominant pathogenic variants are a major cause of epidermolysis bullosa simplex, while other alleles can cause pigmentary disorders such as Dowling-Degos disease.
18 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in KRT5 have source records linked to Epidermolysis bullosa simplex. Association strength is not clinical gene validity.
KRT14: Keratin, type I cytoskeletal 14
It pairs with keratin 5 to provide mechanical strength to basal epidermal keratinocytes. Dominant-negative variants are a major cause of epidermolysis bullosa simplex, while other variants can cause pigmentation disorders or ectodermal phenotypes.
6 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KRT14 have source records linked to Epidermolysis bullosa simplex. Association strength is not clinical gene validity.
Where Epidermolysis bullosa simplex variants cluster
- KRT5 Coil 1A (positions 168–203): 7 of 18 ClinVar pathogenic / likely pathogenic variants, 6.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Epidermolysis bullosa simplex
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KRT5 V186M | 186 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 E466D | 466 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 E466Q | 466 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 L463P | 463 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 A428V | 428 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 E477K | 477 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT14 V133L | 133 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT14 M272T | 272 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 R165S | 165 | Head | Pathogenic / likely pathogenic (★★) |
| KRT5 E170K | 170 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 L196P | 196 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 V323A | 323 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT5 P25L | 25 | Head | Pathogenic / likely pathogenic (★★) |
| KRT5 V186L | 186 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT5 V186E | 186 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT5 A428T | 428 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT14 Y415C | 415 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT5 N193K | 193 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT14 Y129D | 129 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT14 L402R | 402 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT14 L408Q | 408 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT5 Q191E | 191 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT5 T321P | 321 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT5 D328V | 328 | IF rod | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Epidermolysis bullosa simplex
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- SIFT: 97 out of 100
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 92 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Epidermolysis bullosa simplex 2B, generalized intermediate also has ClinVar records linked to KRT5 variants; they fall partly in the same places as the Epidermolysis bullosa simplex variants (5 pathogenic / likely pathogenic).
- Localized epidermolysis bullosa simplex also has ClinVar records linked to KRT5 variants; they fall partly in the same places as the Epidermolysis bullosa simplex variants (3 pathogenic / likely pathogenic).
- Dermatopathia pigmentosa reticularis also has ClinVar records linked to KRT14 variants; they fall mostly in different places as the Epidermolysis bullosa simplex variants (8 pathogenic / likely pathogenic).
- Epidermolysis bullosa simplex, koebner also has ClinVar records linked to KRT14 variants; they fall partly in the same places as the Epidermolysis bullosa simplex variants (7 pathogenic / likely pathogenic).
- Epidermolysis bullosa simplex, dowling-meara also has ClinVar records linked to KRT14 variants; they fall mostly in different places as the Epidermolysis bullosa simplex variants (6 pathogenic / likely pathogenic).
- Localized epidermolysis bullosa simplex also has ClinVar records linked to KRT14 variants; they fall mostly in different places as the Epidermolysis bullosa simplex variants (4 pathogenic / likely pathogenic).
- Epidermolysis bullosa simplex 1D, generalized, intermediate or severe also has ClinVar records linked to KRT14 variants; they fall mostly in different places as the Epidermolysis bullosa simplex variants (4 pathogenic / likely pathogenic).
Diseases related to Epidermolysis bullosa simplex
- Epidermolysis bullosa simplex, dowling-meara, also linked to KRT14 and KRT5
- Epidermolysis bullosa simplex, koebner, also linked to KRT14 and KRT5
- Localized epidermolysis bullosa simplex, also linked to KRT14 and KRT5
- Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, also linked to KRT14 and KRT5
- Dermatopathia pigmentosa reticularis, also linked to KRT14
- Basal cell carcinoma, also linked to KRT5
- Epidermolysis bullosa simplex 2B, generalized intermediate, also linked to KRT5
- Epidermolysis bullosa, also linked to KRT5
- Dowling-Degos disease, also linked to KRT5
- Epidermolysis bullosa simplex 2A, generalized severe, also linked to KRT5
- Epidermolysis bullosa simplex 2C, localized, also linked to KRT5
Frequently asked questions
Which genes have records linked to Epidermolysis bullosa simplex?
This view contains 2 analyzed proteins: KRT5, KRT14. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 24 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 59 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center